Join to View Full Profile
Durham VA Medical Centr, 508 Fulton StPathology & Lab Medicine Service (113)Durham, NC 27705
Phone+1 919-286-6994
Fax+1 919-286-6818
Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a physician-scientist and board certified pathologist specializing in the pharmacologic and transfusion management of bleeding and thrombotic disorders
Education & Training
Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1982 - 1985
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1982
Certifications & Licensure
NC State Medical License 1983 - 2025
FL State Medical License 1986 - 1987
American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- Recombinant factor VIIa: new insights into the mechanism of action through product innovation.Miguel A Escobar, Maureane Hoffman, Giancarlo Castaman, Cedric Hermans, Johnny Mahlangu
Research and Practice in Thrombosis and Haemostasis. 2025-01-01 - 1 citationsEmicizumab promotes factor Xa generation on endothelial cells.Ammon M Fager, Patrick Ellsworth, Nigel S Key, Dougald M Monroe, Maureane Hoffman
Journal of Thrombosis and Haemostasis. 2024-06-01 - 2 citationsUltrasoft platelet-like particles stop bleeding in rodent and porcine models of trauma.Kimberly Nellenbach, Emily Mihalko, Seema Nandi, Drew W Koch, Jagathpala Shetty
Science Translational Medicine. 2024-04-10
Abstracts/Posters
- Characterization of a Novel Human Factor VIIa Chimera with Increased Tissue Factor-Independent Activity for Emergency HemostasisMaureane Hoffman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Biochemical Characteristics of Emicizumab Activity with Factors IXa, X, and VIIa2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other
- Therapeutic uses of recombinant coagulation factor VIIaHoffman M
http://www.uptodate.com/contents/therapeutic-uses-of-recombinant-coagulation-factor-viia
UpToDate, Wolters Kluwer Health - 2012-09-19
Professional Memberships
- Member
- Member
- Member
- American Association of Blood BanksMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
